Abstract
A double-blind study to test the effect of orally administered ribonucleic acid upon the course of senile and arteriosclerotic brain disease failed to confirm the positive findings of other investigators. The authors conclude that RNA administered in this form does not appear to bring about improvement or reversal of senile brain disease.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
